Apr 20 |
Knight Therapeutics (TSE:GUD) shareholders have endured a 21% loss from investing in the stock five years ago
|
Apr 9 |
Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
|
Mar 28 |
Knight Therapeutics Inc. ranks on The Globe and Mail’s fifth-annual Women Lead Here benchmark of executive gender diversity
|
Mar 24 |
Knight Therapeutics Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
|
Mar 22 |
Knight Therapeutics Full Year 2023 Earnings: Misses Expectations
|
Mar 21 |
Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results
|
Mar 14 |
Notice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference Call
|
Mar 7 |
Favourable Signals For Knight Therapeutics: Numerous Insiders Acquired Stock
|
Feb 29 |
Knight Therapeutics Announces Launch of Minjuvi® in Brazil
|
Feb 28 |
Knight Therapeutics Inc. Celebrates its First Decade of Success
|